CWM LLC grew its holdings in shares of Cigna Group (NYSE:CI - Free Report) by 8.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 75,028 shares of the health services provider's stock after buying an additional 6,127 shares during the quarter. CWM LLC's holdings in Cigna Group were worth $24,684,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in CI. TCTC Holdings LLC acquired a new stake in shares of Cigna Group during the 4th quarter valued at approximately $25,000. Putney Financial Group LLC acquired a new stake in shares of Cigna Group during the fourth quarter worth $36,000. Transce3nd LLC acquired a new stake in shares of Cigna Group during the fourth quarter worth $38,000. Wayfinding Financial LLC bought a new position in shares of Cigna Group in the 1st quarter worth about $40,000. Finally, Ameriflex Group Inc. acquired a new position in shares of Cigna Group in the 4th quarter valued at about $44,000. Institutional investors own 86.99% of the company's stock.
Cigna Group Price Performance
NYSE CI traded down $0.35 on Monday, reaching $302.92. 926,226 shares of the stock traded hands, compared to its average volume of 1,824,361. Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a market cap of $80.92 billion, a price-to-earnings ratio of 16.77, a P/E/G ratio of 0.90 and a beta of 0.44. The firm's fifty day simple moving average is $317.02 and its 200 day simple moving average is $310.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.65.
Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, beating the consensus estimate of $6.35 by $0.39. The business had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The company's revenue was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.47 earnings per share. As a group, research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.
Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd were paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 1.99%. The ex-dividend date was Tuesday, June 3rd. Cigna Group's dividend payout ratio is presently 33.44%.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the stock. Guggenheim reissued a "buy" rating and issued a $388.00 target price on shares of Cigna Group in a report on Friday, May 23rd. TD Cowen upgraded Cigna Group to a "strong-buy" rating in a research report on Monday, June 23rd. Robert W. Baird dropped their target price on Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Wall Street Zen upgraded shares of Cigna Group from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, April 8th. Finally, Cantor Fitzgerald increased their price objective on shares of Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a report on Thursday, March 20th. Two analysts have rated the stock with a hold rating, sixteen have issued a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $380.39.
Check Out Our Latest Report on Cigna Group
About Cigna Group
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
